+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Johne's Disease Diagnostics Market by Animal Type, Test Type, End User, Distribution Channel, Technology - Global Forecast to 2030- Product Image
Johne's Disease Diagnostics Market by Animal Type, Test Type, End User, Distribution Channel, Technology - Global Forecast to 2030- Product Image
Sale

Johne's Disease Diagnostics Market by Animal Type, Test Type, End User, Distribution Channel, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666155
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Johne's Disease Diagnostics Market grew from USD 474.87 million in 2024 to USD 542.16 million in 2025. It is expected to continue growing at a CAGR of 13.65%, reaching USD 1.02 billion by 2030.

Understanding the Critical Role of Diagnostics in Johne’s Disease Management

Johne’s Disease remains a formidable challenge for livestock producers, undermining herd health, productivity, and profitability across the globe. Effective management hinges on timely and accurate diagnostic testing, which allows veterinarians and farm managers to identify infected animals early, implement biosecurity measures, and safeguard herd performance. As agricultural stakeholders increasingly recognize the economic and welfare implications of chronic enteritis in ruminants, demand for robust diagnostic solutions has surged.

This report delves into the complex factors shaping the Johne’s Disease diagnostics market, providing a foundational overview of disease epidemiology, diagnostic methodologies, and regulatory contexts. By examining the interplay between pathogen biology, testing protocols, and industry dynamics, the introduction establishes the critical importance of investing in advanced detection tools. Stakeholders can leverage these insights to anticipate market shifts, refine testing strategies, and ultimately protect animal health and farm sustainability.

Pioneering Innovations Redefining Johne’s Disease Detection

The Johne’s Disease diagnostics sphere is undergoing a profound transformation driven by breakthrough technologies and evolving stakeholder expectations. The proliferation of nucleic acid amplification techniques-ranging from conventional PCR to real-time quantitative assays-has elevated sensitivity and reduced turnaround times. Meanwhile, refinements in enzyme-linked immunosorbent assays have improved specificity for subclinical infections, enabling more confident herd health decisions.

Beyond core testing innovations, the integration of data analytics and digital herd management platforms has redefined how diagnostic results inform broader disease control programs. Real-time connectivity between laboratories and farm management software accelerates information flow, allowing veterinarians to implement targeted interventions at scale. Concurrently, growing emphasis on One Health principles has stimulated collaborative research initiatives, fostering convergence between animal health diagnostics and public health surveillance. Together, these trends mark a new era in Johne’s Disease detection-one characterized by speed, precision, and a holistic approach to disease mitigation.

Navigating the Effects of US Tariffs on Diagnostic Supply Chains in 2025

The introduction of new tariffs on imported diagnostic reagents and test kits in 2025 has created notable friction within the Johne’s Disease diagnostics supply chain. Cost pressures on raw materials-particularly specialized culture media components and high-grade antibodies-have translated into elevated list prices for end users. Diagnostic laboratories reliant on cross-border procurement are now reassessing supplier agreements and seeking localized sources to shield operations from further volatility.

In response to tariff-induced margin compression, several manufacturers have moved production closer to key markets, establishing regional centers of excellence for culture reagents and immunoassay kits. These strategic shifts aim to mitigate transportation overheads and currency fluctuations while preserving quick delivery timelines. At the same time, end users are diversifying their testing portfolios to include a greater mix of in-house PCR and ELISA assays, balancing cost efficiency with diagnostic accuracy. This recalibration underscores the market’s resilience and its capacity to adapt supply chain strategies amid evolving trade policies.

Deep Dive into Market Segmentation for Targeted Diagnostic Strategies

A nuanced understanding of market segmentation is essential for stakeholders seeking precise positioning and product development. When dissecting demand by animal type, larger populations of dairy cattle drive significant testing volume, yet emerging dairy goat enterprises are catalyzing parallel growth in goat-specific assay adoption. Beef cattle operations, although smaller in individual herd size, still represent a substantial segment for herd-level screening, with sheep flocks contributing to regional pockets of specialized testing need.

Examining the test type dimension reveals that liquid and solid media cultures remain foundational for definitive pathogen identification, even as competitive, indirect, and sandwich ELISAs capture wider use for herd-level surveillance. The ongoing transition toward real-time PCR highlights the market’s appetite for rapid, quantitative results, supplemented by conventional PCR in resource-constrained settings. End-user insights further illuminate that large hospital and independent laboratories maintain the highest throughput, while breeding and dairy farms increasingly adopt point-of-care ELISA kits. Veterinary clinics, from solo practices to large clinical networks, represent a growing channel for bundled diagnostic packages, sold directly or via distribution partners.

Distribution channels themselves are evolving: manufacturers are balancing direct sales relationships with national and regional distributor networks while exploring online platforms for reagent and kit replenishment. Underpinning these channels is a technology axis where DNA-based approaches, immunoassays, and microbial culture techniques interweave. Within DNA-based testing, LAMP and qPCR surge alongside traditional PCR, while immunoassay formats expand beyond agar gel immunodiffusion and ELISA. Liquid and solid media cultures remain indispensable, ensuring pathogen viability for epidemiological and confirmatory testing. Recognition of these overlapping segments enables market participants to tailor offerings and optimize resource allocation for maximum impact.

Regional Dynamics Shaping Global Johne’s Disease Diagnostics Demand

Regional dynamics play a pivotal role in dictating market trajectories and investment priorities. In the Americas, a robust dairy and beef production infrastructure underpins substantial demand for Johne’s Disease diagnostics, supported by progressive herd-health regulations and well-established laboratory networks. North America leads in technology adoption, particularly for real-time PCR assays, while Latin America shows potential for growth as diagnostic awareness spreads among emerging livestock producers.

Across Europe, the Middle East, and Africa, regulatory harmonization initiatives and animal welfare standards drive diagnostic uptake. Western European nations exhibit high ELISA penetration for routine surveillance, whereas Eastern European markets are investing in capacity building for culture-based confirmations. Middle Eastern producers, often concentrated in high-value dairy operations, seek rapid PCR-based diagnostics to protect herd performance, and African markets are witnessing pilot programs that combine immunoassay screening with novel field-deployable tests to overcome infrastructural challenges.

Asia-Pacific presents a mosaic of mature and developing markets. Australia and New Zealand have well-entrenched Johne’s Disease control programs, leveraging both culture and immunoassay workflows. In contrast, large-scale dairy industries in China and India are accelerating the adoption of automated ELISA platforms, while Southeast Asian countries pilot cost-effective LAMP protocols to enhance on-farm testing. These regional nuances underscore the importance of localized strategies that align product offerings with regulatory frameworks, technology readiness, and farming practices.

Strategic Movements by Leading Players Accelerating Market Evolution

Key industry players are deploying a mix of strategic alliances, product innovation, and geographic expansion to consolidate their foothold in the Johne’s Disease diagnostics arena. One leading global life sciences firm has enhanced its portfolio with a multiplex real-time PCR assay capable of simultaneous pathogen detection and strain differentiation, addressing the demand for rapid confirmation. Another multinational diagnostics specialist has forged collaboration agreements with regional distributors, unlocking access to under-penetrated markets in Eastern Europe and Latin America.

Meanwhile, a veterinary diagnostics innovator has invested in proprietary ELISA formats that reduce cross-reactivity with related mycobacteria, elevating assay specificity for early-stage infections. This same company is scaling up an online direct-sales portal to streamline reagent replenishment for farms and small laboratories. A diversified agritech enterprise has pursued strategic acquisitions of niche molecular diagnostics startups, integrating LAMP-based test kits into its existing immunoassay and culture product lines. These concerted efforts reflect a broader competitive push toward end-to-end diagnostic solutions, combining in-house testing, remote reporting capabilities, and technical support services to deepen customer engagement and loyalty.

Targeted Actions to Strengthen Market Position and Drive Growth

Industry leaders should prioritize the expansion of molecular diagnostics capabilities by channeling resources into multiplex real-time PCR and LAMP platforms that offer rapid and comprehensive pathogen profiling. Strengthening partnerships with national and regional distributors will be critical to overcoming logistical barriers and ensuring consistent supply, particularly in developing markets where regulatory pathways may be nascent.

To maximize market penetration, stakeholders must also invest in digital integration, linking laboratory information management systems with farm management software to deliver actionable insights directly to end users. Customized assay bundles that combine screening and confirmatory tests can further enhance value perception, especially among large-scale dairy operations seeking turnkey solutions. Finally, aligning product development roadmaps with evolving regulatory frameworks and animal welfare standards will help companies maintain compliance while addressing the increasing scrutiny of diagnostic accuracy and traceability.

Rigorous Data Collection and Analysis Framework Ensuring Insight Accuracy

This research methodology blends primary engagements with laboratory directors, veterinary advisors, and diagnostic procurement managers alongside rigorous secondary data collection from peer-reviewed journals, regulatory databases, and industry white papers. Quantitative data points were triangulated against company filings, trade statistics, and market intelligence to ensure consistency and reliability. Each market segment underwent cross-validation through expert consultations to confirm the relevance of animal type, test type, end user, distribution channel, and technology classifications.

Qualitative insights were enriched by regional workshops and virtual roundtables, where participants discussed emerging diagnostic paradigms and supply chain adaptations. All data inputs were subjected to quality assurance protocols, including outlier analysis and methodological audits, to uphold the integrity of findings. This comprehensive framework guarantees that the analyses presented herein reflect both the current state and the latent potential of the Johne’s Disease diagnostics market.

Integrating Insights to Forge a Competitive Advantage

The Johne’s Disease diagnostics market stands at a crossroads where innovation, regulation, and global trade dynamics converge. Technological strides in PCR and immunoassay formats have unlocked unprecedented diagnostic performance, yet supply chain disruptions and tariff shifts underscore the need for agile sourcing strategies. Segmentation insights reveal diverse demand drivers across livestock types, test formats, user profiles, channels, and technologies, emphasizing the importance of tailored approaches.

Regionally differentiated growth patterns-from the mature North American laboratory infrastructure to the emerging Asia-Pacific field testing initiatives-highlight both opportunities and challenges for market participants. Leading companies are responding with strategic alliances, product line expansions, and digital platform investments, positioning themselves to capture share in this evolving landscape. By integrating these insights into strategic planning, stakeholders can navigate complexity, capitalize on technological momentum, and ultimately enhance herd health outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Cattle
      • Beef Cattle
      • Dairy Cattle
    • Sheep & Goats
      • Goats
      • Sheep
  • Test Type
    • Culture
      • Liquid Media Culture
      • Solid Media Culture
    • ELISA
      • Competitive ELISA
      • Indirect ELISA
      • Sandwich ELISA
    • PCR
      • Conventional PCR
      • Real-Time PCR
  • End User
    • Diagnostic Labs
      • Hospital Labs
      • Independent Labs
    • Farms
      • Breeding Farms
      • Dairy Farms
    • Research Institutes
    • Veterinary Clinics
      • Independent Clinics
      • Large Clinics
  • Distribution Channel
    • Direct Sales
    • Distributors
      • National Distributors
      • Regional Distributors
    • Online
  • Technology
    • DNA-Based
      • LAMP
      • PCR
      • qPCR
    • Immunoassay
      • Agar Gel Immunodiffusion
      • ELISA
    • Microbial Culture
      • Liquid Media
      • Solid Media
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Neogen Corporation
  • Abaxis, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories, Inc.
  • QIAGEN N.V.
  • Biocontrol Systems, LLC
  • SeQuent Scientific Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Johne's Disease Diagnostics Market, by Animal Type
8.1. Introduction
8.2. Cattle
8.2.1. Beef Cattle
8.2.2. Dairy Cattle
8.3. Sheep & Goats
8.3.1. Goats
8.3.2. Sheep
9. Johne's Disease Diagnostics Market, by Test Type
9.1. Introduction
9.2. Culture
9.2.1. Liquid Media Culture
9.2.2. Solid Media Culture
9.3. ELISA
9.3.1. Competitive ELISA
9.3.2. Indirect ELISA
9.3.3. Sandwich ELISA
9.4. PCR
9.4.1. Conventional PCR
9.4.2. Real-Time PCR
10. Johne's Disease Diagnostics Market, by End User
10.1. Introduction
10.2. Diagnostic Labs
10.2.1. Hospital Labs
10.2.2. Independent Labs
10.3. Farms
10.3.1. Breeding Farms
10.3.2. Dairy Farms
10.4. Research Institutes
10.5. Veterinary Clinics
10.5.1. Independent Clinics
10.5.2. Large Clinics
11. Johne's Disease Diagnostics Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.3.1. National Distributors
11.3.2. Regional Distributors
11.4. Online
12. Johne's Disease Diagnostics Market, by Technology
12.1. Introduction
12.2. DNA-Based
12.2.1. LAMP
12.2.2. PCR
12.2.3. qPCR
12.3. Immunoassay
12.3.1. Agar Gel Immunodiffusion
12.3.2. ELISA
12.4. Microbial Culture
12.4.1. Liquid Media
12.4.2. Solid Media
13. Americas Johne's Disease Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Johne's Disease Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Johne's Disease Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. IDEXX Laboratories, Inc.
16.3.2. Zoetis Inc.
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Neogen Corporation
16.3.5. Abaxis, Inc.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Abbott Laboratories, Inc.
16.3.8. QIAGEN N.V.
16.3.9. Biocontrol Systems, LLC
16.3.10. SeQuent Scientific Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. JOHNE'S DISEASE DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. JOHNE'S DISEASE DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. JOHNE'S DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. JOHNE'S DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. JOHNE'S DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. JOHNE'S DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LARGE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LAMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY AGAR GEL IMMUNODIFFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 100. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 102. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 103. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 104. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 105. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 106. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 107. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 109. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 110. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 113. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 115. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 116. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 119. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 123. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 124. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 132. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 203. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 204. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 205. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 206. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 208. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 209. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 210. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 213. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 218. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 219. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 220. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 221. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 222. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 223. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 224. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 225. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 226. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 227. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 229. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 235. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 236. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 254. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 255. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 256. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 257. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 258. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 259. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 260. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 261. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 263. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 264. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 265. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 267. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 269. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 270. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 271. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 272. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 273. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 274. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 275. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 276. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 277. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 278. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 280. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 281. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 282. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 284. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 286. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 287. SPAIN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Johne's Disease Diagnostics market report include:
  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Neogen Corporation
  • Abaxis, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories, Inc.
  • QIAGEN N.V.
  • Biocontrol Systems, LLC
  • SeQuent Scientific Limited

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 542.16 Million
Forecasted Market Value ( USD ) by 2030 $ 1020 Million
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Johne's Disease Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Sheep), By Test Type (ELISA, PCR), By End-use (Veterinary Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Johne's Disease Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Sheep), By Test Type (ELISA, PCR), By End-use (Veterinary Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Johne's Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Johne's Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Veterinary Rapid Test Market by Animal Type, Product Type, End User, Technology, Application, Distribution Channel - Global Forecast to 2030 - Product Image

Veterinary Rapid Test Market by Animal Type, Product Type, End User, Technology, Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Cattle & Porcine/Swine Reproductive Diseases Market by Disease Type, Animal Type, Diagnosis Type, Treatment Type, End-User - Global Forecast to 2030 - Product Image

Cattle & Porcine/Swine Reproductive Diseases Market by Disease Type, Animal Type, Diagnosis Type, Treatment Type, End-User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Veterinary Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Veterinary Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Market

Johne's disease, also known as paratuberculosis, is a chronic infectious disease that affects the intestinal tract of ruminant animals, such as cattle, sheep, goats, and deer. Caused by the bacterium ''Mycobacterium avium'' subsp. ''paratuberculosis'' (MAP), the disease results in weight loss, diarrhea, decreased milk production, and eventually death. The diagnosis of Johne's disease is complex due to the slow progression of the infection and the difficulty of detecting the organism in the early stages. The market for Johne's disease diagnostics within animal healthcare encompasses a range of tests and services aimed at identifying and managing the condition in livestock populations. Diagnostic methods include serological tests such as ELISA (enzyme-linked immunosorbent assay), which detects antibodies against MAP, and fecal culture or PCR (polymerase chain reaction) tests to identify the presence of the bacterium itself. The development of accurate and rapid diagnostic tools is crucial for early detection, which enables better management and control of the disease through biosecurity measures, vaccination, and targeted culling of infected animals. Several companies participate in the Johne's disease diagnostics market, offering various testing solutions and tools for veterinarians and livestock producers. Notable firms in this sector include IDEXX Laboratories, Thermo Fisher Scientific, Zoetis, Prionics, Bio-Rad Laboratories, and Merck Animal Health. These companies provide a range of diagnostic products and Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.